Transplant patients may one day be completely free from grueling regimens of immunosuppressive drugs, according to researchers from India, Stanford University, and the University of Pittsburgh. The investigators presented findings from three studies at the recent 19th International Congress of The Transplantation Society, which was held in Miami, Fla.
